OCREVUS ocrelizumab 920 mg/23 mL solution for injection vial

Roche Products Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: c5bb3d32b5082be2
Product Name: OCREVUS ocrelizumab 920 mg/23 mL solution for injection vial
Artg Id: 446150
Artg Name: OCREVUS ocrelizumab 920 mg/23 mL solution for injection vial
Sponsor: Roche Products Pty Ltd
Company Detail Path: /organization/roche-products-pty-ltd
Artg Date: 2025-03-27
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/a1e4426483966cef9ca6803266f266d0.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/bd02fa998954b66bb98b821deaab3c29.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

c5bb3d32b5082be2

Type

Standard